Evaluating the efficacy of intragastric botulinum toxin a injections with two different quantities and sites for obesity
PLOS One · 2025
DOI: 10.1371/journal.pone.0339259 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Tien-Yow Chuang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physical Medicine and Rehabilitation, China Medical University Hospital, Taichung, Taiwan. Hauptthemen laut MEDLINE: Botulinum Toxins, Type A, Obesity. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Medical University.
Abstract (Originalsprache)
Introduction
Intragastric injections of botulinum toxin A (BTX-A) have shown promise in aiding weight reduction among obese patients, with a favorable safety profile and minimal adverse effects; however, the inconsistent results from prior studies highlight the need to examine key factors in the research of intragastric injection of botulinum toxin A, such as the dosage of BTX-A, the number and placement of injections. This study examines the efficacy of varying high doses, multi-gastric sites botulinum toxin A injections for weight control. Materials and Methods A total of 103 patients aged 18–65 with a BMI ≥ 25 kg/m² were assigned to four groups receiving endoscopic BTX-A injections at varying doses and sites: Group 1 (400 IU, fundus and body), Group 2 (300 IU, fundus and body), Group 3 (400 IU, antrum and body), and Group 4 (300 IU, antrum and body). Baseline comparisons used ANOVA, while a mixed model assessed the interaction among injection site, dose, and time on outcomes.
Results
Baseline measures showed no group differences in bodyweight, BMI, or body fat. The mixed model indicated significant reductions in bodyweight, BMI, and body fat with gastric fundus and body injections. Site and dose interactions significantly affected bodyweight (p = 0.024) and body fat (p = 0.041), but not BMI.
Conclusions
Endoscopic intragastric BTX-A injections effectively reduce body weight, BMI, and body fat, particularly with injections in the fundus and body regions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Physical Medicine and Rehabilitation, China Medical University Hospital, Taichung, Taiwan.
- Department of Physical Medicine and Rehabilitation, School of Medicine, China Medical University, Taichung, Taiwan.
- Department of Physical Medicine and Rehabilitation, Taichung Municipal Geriatric Rehabilitation General Hospital, Taichung, Taiwan.
- Department of Plastic and Aesthetic, Genesis Clinic, Taipei, Taiwan.
- Division of Physical Medicine and Rehabilitation, Fu Jen Catholic University Hospital, New Taipei City, Taiwan.
- School of Medicine, Fu Jen Catholic University, Taipei, Taiwan.
ORCID-Profile: Cheng-Di Chiu
Förderung
- China Medical University
Zitieren
APA
Chuang, T. Y., Chiu, C. H., Penn, I. W., & Chiu, C. D. (2025). Evaluating the efficacy of intragastric botulinum toxin a injections with two different quantities and sites for obesity. PLOS One. https://doi.org/10.1371/journal.pone.0339259
Vancouver
Chuang TY, Chiu CH, Penn IW, Chiu CD. Evaluating the efficacy of intragastric botulinum toxin a injections with two different quantities and sites for obesity. PLOS One. 2025. doi:10.1371/journal.pone.0339259
BibTeX
@article{Chuang2025,
author = {Chuang, Tien-Yow and Chiu, Cheng-Hung and Penn, I-Wen and Chiu, Cheng-Di},
title = {Evaluating the efficacy of intragastric botulinum toxin a injections with two different quantities and sites for obesity},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0339259}
}
EUVIMED